Download PDF
Horm Metab Res 2003; 35(4): 236-242
DOI: 10.1055/s-2003-39480
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Growth Hormone-Mediated Breakdown of Body Fat: Insulin and Leptin Responses to GH are Modulated by Diet Composition and Caloric Intake in Old Rats

K.  Malmlöf1 , T.  Johansen1
  • 1Department of Pharmacology 3, Pharmacology Research and Development, Novo Nordisk, Malov, Denmark.
Further Information

Publication History

Received 4 October 2002

Accepted after Revision 9 December 2002

Publication Date:
02 June 2003 (online)

Also available at
    Permissions and Reprints

Abstract

This work was performed to elucidate whether growth hormone (GH)-mediated loss of adipose tissue and responses in plasma insulin and leptin are modulated by diet composition. 12-month-old rats were first fed a high-fat (HF) diet or a low-fat (LF) diet for 14 weeks. After that, GH or saline was administered to rat groups that were maintained on either HF or LF diets or that were switched from the HF to the LF diet. All 6 groups had free access to food. One additional saline group was pair-fed with the GH group that was switched from the HF to the LF diet. The caloric consumption of this latter group was also translated to yet another GH group receiving restricted amounts of the HF diet. GH was given in a total dose of 4 mg/kg/d for three weeks. After sacrifice, blood was collected and tissues were excised. In groups injected with saline, the weight of excised adipose tissue was 60 ± 4.7, 41 ± 3.8 and 50 ± 4.5 g in animals that continued with the HF diet, LF diet, or that were switched from HF to LF, respectively. Corresponding figures after GH treatment were significantly (p < 0.05) decreased to 38 ± 2.7, 30 ± 2.3, and 31 ± 2.7 g, respectively. Pair-feeding had no effect, whereas only 26 ± 3.0 g of adipose tissue was retrieved in rats fed restricted amounts of HF diet while receiving GH. In this group, plasma insulin and leptin were also significantly (p < 0.05) depressed compared with other GH groups, especially to the group fed the unrestricted HF diet (203 ± 35 vs. 1345 ± 160 pmol/l and 9.3 ± 1.2 vs. 31 ± 4.4 µg/l). In conclusion, this study shows that GH mediates breakdown of adipose tissue under a variety of dietary conditions, and that induction of hyperinsulinemia can be prevented if GH treatment is combined with restricted feeding of a diet which is relatively low in carbohydrates and rich in fat. This will also promote a fall of plasma leptin.

Key words

Adipose-tissue - Body composition - High-fat diet - Muscle - Obesity - Lipolysis

References

  • 1 Clapham J C, Arch J R, Tadayyon M. Anti-obesity drugs: a critical review of current therapies and future opportunities.  Pharmacol Ther. 2001;  89 81-121
    CrossrefPubMedGoogle Scholar
  • 2 Skaggs S R, Crist D M. Exogenous human growth hormone reduces body fat in obese women.  Horm Res. 1991;  35 19-24
    PubMedGoogle Scholar
  • 3 Richelsen B, Pedersen S B, Borglum J D, Moller-Pedersen T, Jorgensen J, Jorgensen J O. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity.  Am J Physiol. 1994;  266 E211-E216
    PubMedGoogle Scholar
  • 4 Snyder D K, Underwood L E, Clemmons D R. Persistent lipolytic effect of exogenous growth hormone during caloric restriction.  Am J Med. 1995;  98 129-134
    CrossrefPubMedGoogle Scholar
  • 5 Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson B A. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure [see comments].  J Clin Endocrinol Metab. 1997;  82 727-734
    CrossrefPubMedGoogle Scholar
  • 6 Cuneo R C, Judd S, Wallace J D, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung N W, Hurley D. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH- Deficient Adults.  J Clin Endocrinol Metab. 1998;  83 107-116
    CrossrefPubMedGoogle Scholar
  • 7 Kim K R, Nam S Y, Song Y D, Lim S K, Lee H C, Huh K B. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.  Horm Res. 1999;  51 78-84
    CrossrefPubMedGoogle Scholar
  • 8 Isley W L, Underwood L E, Clemmons D R. Dietary components that regulate serumsomatomedin-C concentrations in humans.  J Clin Invest. 1983;  71 175-182
    PubMedGoogle Scholar
  • 9 Snyder D K, Clemmons D R, Underwood L E. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.  J Clin Endocrinol Metab. 1989;  69 745-752
    PubMedGoogle Scholar
  • 10 Sanchez-Gomez M, Malmlof K, Mejia W, Bermudez A, Ochoa M T, Carrasco-Rodriguez S, Skottner A. Insulin-like growth factor-I, but not growth hormone, is dependent on a high protein intake to increase nitrogen balance in the rat.  Br J Nutr. 1999;  81 145-152
    PubMedGoogle Scholar
  • 11 Snyder D K, Underwood L E, Clemmons D R. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.  Am J Clin Nutr. 1990;  52 431-437
    PubMedGoogle Scholar
  • 12 Drent M L, Wever L D, Ader H J, van der Veen E A. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects.  Eur J Endocrinol. 1995;  132 565-572
    PubMedGoogle Scholar
  • 13 Tagliaferri M, Scacchi M, Pincelli A I, Berselli M E, Silvestri P, Montesano A, Ortolani S, Dubini A, Cavagnini F. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.  Int J Obes Relat Metab Disord. 1998;  22 836-841
    CrossrefPubMedGoogle Scholar
  • 14 Nam S Y, Kim K R, Cha B S, Song Y D, Lim S K, Lee H C, Huh K B. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.  Int J Obes Relat Metab Disord. 2001;  25 1101-1107
    CrossrefPubMedGoogle Scholar
  • 15 Mendel V E. Influence of the insulin-to-growth hormone ratio on body composition of mice.  Am J Physiol. 1980;  238 E231-E234
    PubMedGoogle Scholar
  • 16 Jeffcoate W. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence.  Drug Saf. 2002;  25 199-212
    PubMedGoogle Scholar
  • 17 Shulman D I. Metabolic effects of growth hormone in the child and adolescent.  Curr Opin Pediatr. 2002;  14 432-436
    CrossrefPubMedGoogle Scholar
  • 18 Malmlof K, Din N, Johansen T, Pedersen S B. Growth hormone affects both adiposity and voluntary food intake in old and obese female rats.  Eur J Endocrinol. 2002;  146 121-128
    CrossrefPubMedGoogle Scholar
  • 19 Malmlof K, Johansen P B, Haahr P M, Wilken M, Oxlund H. Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.  Growth Horm IGF Res. 1999;  9 445-450
    PubMedGoogle Scholar
  • 20 Johansen T, Deckert M, Mandrup-Poulsen T, Malmlof K. The role of growth hormone and glucocorticoid in glucose handling in vivo. .  J Endocrinol. 1999;  162 87-93
    CrossrefPubMedGoogle Scholar
  • 21 Lin X, Chavez M R, Bruch R C, Kilroy G E, Simmons L A, Lin L, Braymer H D, Bray G A, York D A. The effects of a high fat diet on leptin mRNA, serum leptin and the response to leptin are not altered in a rat strain susceptible to high fat diet-induced obesity.  J Nutr. 1998;  128 1606-1613
    PubMedGoogle Scholar
  • 22 Schwartz M W, Woods S C, Porte D, Seeley R J, Baskin D G. Central nervous system control of food intake.  Nature. 2000;  404 661-671
    CrossrefPubMedGoogle Scholar
  • 23 van Dijk G. The role of leptin in the regulation of energy balance and adiposity.  J Neuroendocrinol. 2001;  13 913-921
    CrossrefPubMedGoogle Scholar
  • 24 Masuzaki H, Ogawa Y, Hosoda K, Kawada T, Fushiki T, Nakao K. Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet.  Biochem Biophys Res Commun. 1995;  216 355-358
    CrossrefPubMedGoogle Scholar
  • 25 Stricker-Krongrad A, Cumin F, Burlet C, Beck B. Hypothalamic neuropeptide Y and plasma leptin after long-term high-fat feeding in the rat.  Neurosci Lett. 1998;  254 157-160
    CrossrefPubMedGoogle Scholar
  • 26 Roberts C K, Berger J J, Barnard R J. Long-term effects of diet on leptin, energy intake, and activity in a model of diet-induced obesity.  J Appl Physiol. 2002;  93 887-893
    PubMedGoogle Scholar
  • 27 Steinberg G R, Dyck D J. Development of leptin resistance in rat soleus muscle in response to high-fat diets.  Am J Physiol Endocrinol Metab. 2000;  279 E1374-E1382
    PubMedGoogle Scholar
  • 28 Rolls B J, Rowe E A, Turner R C. Persistent obesity in rats following a period of consumption of a mixed, high energy diet.  J Physiol (Lond). 1980;  298 415-427
    PubMedGoogle Scholar
  • 29 Azain M J, Hausman D B, Kasser T R, Martin R J. Effect of somatotropin and feed restriction on body composition and adipose metabolism in obese Zucker rats.  Am J Physiol. 1995;  269 E137-E144
    PubMedGoogle Scholar
  • 30 al Shoumer K A, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston D G. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.  Clin Endocrinol (Oxf). 1998;  48 795-802
    CrossrefPubMedGoogle Scholar
  • 31 Isozaki O, Tsushima T, Miyakawa M, Nozoe Y, Demura H, Seki H. Growth hormone directly inhibits leptin gene expression in visceral fat tissue in fatty Zucker rats.  J Endocrinol. 1999;  161 511-516
    CrossrefPubMedGoogle Scholar
  • 32 Karlsson C, Stenlof K, Johannsson G, Marin P, Bjorntorp P, Bengtsson B A, Carlsson B, Carlsson L M, Sjostrom L. Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men.  Eur J Endocrinol. 1998;  138 408-414
    CrossrefPubMedGoogle Scholar
  • 33 Garibotto G, Barreca A, Sofia A, Russo R, Fiorini F, Cappelli G, Cavatorta F, Cesarone A, Franceschini R, Sacco P, Minuto F, Barreca T. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition.  J Am Soc Nephrol. 2000;  11 2106-2113
    PubMedGoogle Scholar
  • 34 Houseknecht K L, Portocarrero C P, Ji S, Lemenager R, Spurlock M E. Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-1 expression.  J Endocrinol. 2000;  164 51-57
    CrossrefPubMedGoogle Scholar
  • 35 Cooling J, Barth J, Blundell J. The high-fat phenotype: is leptin involved in the adaptive response to a high fat (high energy) diet?.  Int J Obes Relat Metab Disord. 1998;  22 1132-1135
    CrossrefPubMedGoogle Scholar
  • 36 Walker C G, Bryson J M, Phuyal J L, Caterson I D. Dietary modulation of circulating leptin levels: site-specific changes in fat deposition and ob mRNA expression.  Horm Metab Res. 2002;  34 176-181
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Ahren B. Plasma leptin and insulin in C57BI/6J mice on a high-fat diet: relation to subsequent changes in body weight.  Acta Physiol Scand. 1999;  165 233-240
    CrossrefPubMedGoogle Scholar
  • 38 Ahren B, Mansson S, Gingerich R L, Havel P J. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting.  Am J Physiol. 1997;  273 R113-R120
    PubMedGoogle Scholar

Dr. K. Malmlöf

Novo Nordisk A/S

Novo Nordisk Park · 2760 Malov · Denmark

Phone: +45 (44) 43 92 09 ·

Fax: +45 (44) 43 80 06

Email: kmal@novonordisk.com

      >